Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.

作者: Karen H. Lu , Judy E. Garber , Daniel W. Cramer , William R. Welch , Jonathan Niloff

DOI: 10.1200/JCO.2000.18.14.2728

关键词:

摘要: PURPOSE: To review the findings at prophylactic oophorectomy of a series women who presented to familial breast and ovarian cancer clinic. MATERIALS AND METHODS: Data from medical charts, operative notes, pathology reports were collected on had undergone oophorectomies because elevated risk cancer. Because only subset patients underwent BRCA1 BRCA2 testing, each patient’s hereditary predisposition was calculated using Berry-Parmigiani model family history data. RESULTS: From June 1989 December 1998, 50 seen our clinic oophorectomy, 33 whom carrying germline or mutation greater than 25%. Among this group, four incidental tumors found (four 33, 12%); one tumor noted time surgery three in final pathology. Two microscopic, poorly differentiated serous adenocarcinomas multiple sites both ovarie...

参考文章(15)
O T Jóhannsson, J Ranstam, A Borg, H Olsson, Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. Journal of Clinical Oncology. ,vol. 16, pp. 397- 404 ,(1998) , 10.1200/JCO.1998.16.2.397
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
Michael G. Muto, Daniel W. Cramer, Douglas L. Brown, William R. Welch, Bernard L. Harlow, Huijuan Xu, Judy P. Brucks, Sai-Wah Tsao, Ross S. Berkowitz, Screening for ovarian cancer : the preliminary experience of a familial ovarian cancer center Gynecologic Oncology. ,vol. 51, pp. 12- 20 ,(1993) , 10.1006/GYNO.1993.1239
JoanneK. Tobacman, MargaretA. Tucker, Ronald Kase, MarkH. Greene, Jose Costa, JosephF. Fraumeni, INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES The Lancet. ,vol. 320, pp. 795- 797 ,(1982) , 10.1016/S0140-6736(82)92681-2
Giovanni Parmigiani, Donald A. Berry, Omar Aguilar, Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2 American Journal of Human Genetics. ,vol. 62, pp. 145- 158 ,(1998) , 10.1086/301670
Beth Y. Karlan, Rae Lynn Baldwin, Eloise Lopez-Luevanos, Leslie J. Raffel, Denise Barbuto, Steven Narod, Lawrence D. Platt, Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. American Journal of Obstetrics and Gynecology. ,vol. 180, pp. 917- 928 ,(1999) , 10.1016/S0002-9378(99)70663-0
Karen H Lu, Daniel W Cramer, Michael G Muto, Evelyn Y Li, Jonathan Niloff, Samuel C Mok, A population-based study of brca1 and brca2 mutations in jewish women with epithelial ovarian cancer Obstetrics & Gynecology. ,vol. 93, pp. 34- 37 ,(1999) , 10.1016/S0029-7844(98)00362-7
T. R. Rebbeck, A. M. Levin, A. Eisen, C. Snyder, P. Watson, L. Cannon-Albright, C. Isaacs, O. Olopade, J. E. Garber, A. K. Godwin, M. B. Daly, S. A. Narod, S. L. Neuhausen, H. T. Lynch, B. L. Weber, Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers Journal of the National Cancer Institute. ,vol. 91, pp. 1475- 1479 ,(1999) , 10.1093/JNCI/91.17.1475
Deborah Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, B Weber, G Lenoir, J Chang-Claude, H Sobol, M Dawn Teare, J Struewing, A Arason, S Scherneck, J Peto, TR Rebbeck, P Tonin, S Neuhausen, R Barkardottir, J Eyfjord, H Lynch, BAJ Ponder, SA Gayther, JM Birch, A Lindblom, D Stoppa-Lyonnet, Y Bignon, A Borg, U Hamann, N Haites, RJ Scott, CM, and Maugard, H Vasen, S Seitz, LA Cannon-Albright, A Schofield, M Zelada-Hedman, Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families American Journal of Human Genetics. ,vol. 62, pp. 676- 689 ,(1998) , 10.1086/301749